Order Article Reprints

Gabriel R, Boukichou-Abdelkader N, Gilis-Januszewska A, Makrilakis K, Gómez-Huelgas R, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A, et al. Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine. 2023; 12(5):2035. https://doi.org/10.3390/jcm12052035

Gabriel, Rafael, Nisa Boukichou-Abdelkader, Aleksandra Gilis-Januszewska, Konstantinos Makrilakis, Ricardo Gómez-Huelgas, Zdravko Kamenov, Bernhard Paulweber, Ilhan Satman, Predrag Djordjevic, Abdullah Alkandari, and et al. 2023. "Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial" Journal of Clinical Medicine 12, no. 5: 2035. https://doi.org/10.3390/jcm12052035

Gabriel, R., Boukichou-Abdelkader, N., Gilis-Januszewska, A., Makrilakis, K., Gómez-Huelgas, R., Kamenov, Z., Paulweber, B., Satman, I., Djordjevic, P., Alkandari, A., Mitrakou, A., Lalic, N., Egido, J., Más-Fontao, S., Calvet, J. H., Pastor, J. C., Lindström, J., Lind, M., Acosta, T., ... on behalf of the e-PREDICE Consortium. (2023). Reduction in the Risk of Peripheral Neuropathy and Lower Decrease in Kidney Function with Metformin, Linagliptin or Their Fixed-Dose Combination Compared to Placebo in Prediabetes: A Randomized Controlled Trial. Journal of Clinical Medicine, 12(5), 2035. https://doi.org/10.3390/jcm12052035